NewBiologix SA
Gene and Cell Therapies
NewBiologix SA emerged from stealth today as a technology innovation company developing a proprietary and breakthrough platform for the advanced engineering of cell lines used to manufacture gene and cell therapies. The Companys DNA-based platform is being developed to address key manufacturing challenges associated with the production of recombinant adeno-associated virus (rAAV) vectors used to produce advanced therapy medicinal products (ATMPs).
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
16.01.2025
Swiss startups strengthen presence in North America (startupticker.ch)
11.05.2023
NewBiologix launches with $50M to make gene therapies more viable (startupticker.ch)
No milestones
No Jobs
No videos and documents
No Awards
NewBiologix SA
Gene and Cell Therapies
Website:
www.swissbiotech.org/listing/newbiologix-sa/
Headquarter:
Epalinges
Foundation Date:
March 2022
Technology:
- Biotech